10.30.19

Regenxbio Exercises Option for Global License for Use of SCS Microinjector in AAV Gene Therapy Delivery

Source: Clearside Biomedical

10.24.19

Adverum Biotechnologies Doses First Patient in Third Cohort of OPTIC Clinical Trial of Intravitreal Gene Therapy for Wet AMD

Source: Adverum Biotechnologies

10.12.19

AAO: In-Office Gene Therapy for Wet AMD is Coming

Source: American Academy of Ophthalmology

10.12.19

Kodiak Sciences Announces Data from Ongoing Phase 1b Study of KSI-301 in Patients With Wet AMD, DME and RVO

Source: Kodiak Sciences

10.12.19

Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Wet AMD

Source: Allergan

10.12.19

Regenxbio Announces Additional Positive Interim Phase 1/2a Trial Update for RGX-314 for the Treatment of Wet AMD

Source: Regenxbio

10.11.19

PanOptica: Anti-VEGF Eye Drop Shows Promise in Treatment of Wet AMD

Source: PanOptica

10.08.19

Novartis Receives FDA Approval for Beovu for Wet AMD

Source: Novartis

10.07.19

Kodiak Sciences Announces Presentation of Durability Data from Clinical Development Program of KSI-301 in Wet AMD, DME, and RVO at AAO

Source: Kodiak Sciences

10.04.19

Johns Hopkins Researchers Advance Search For Safer, Easier Way to Deliver Vision-Saving Gene Therapy to The Retina

Source: Johns Hopkins Medicine

View more stories